Companies: 10,795·Total market cap: $144.5T

Bioxytran, Inc.

Bioxytran, Inc.

BIXTOTCHealthcare● Active

$0.03

$-0.00(-1.95%)

Market Cap$3448696

P/E Ratio—

52W High$0.145

52W Low$0.0262

Avg Volume305K

Open$0.03

Beta1.82

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Bioxytran, Inc.（BIXT）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · BIXT · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-0.03Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding91.8MShares outstanding history

Next EarningsTBAEarnings history

探索 Bioxytran, Inc. 数据

分析师预测—

股息不分红

盈利EPS $-0.02-35.09%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$2.1M▲ +10.29% YoY

202320242025

FY 2025EPS$-0.02▼ 35.09% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$2.8MEPS: $-0.03View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Bioxytran, Inc.

$0.03-1.95%$3.4M #2

BetterLife Pharma Inc.

$0.04+5.16%$7.2M #3

BioVaxys Technology Corp.

$0.11-39.61%$3.2M #4

Burzynski Research Institute, Inc.

$0.01+15.58%$1.4M #5

Mosaic ImmunoEngineering Inc.

$0.69+3.03%$5.0M #6

Glow Lifetech Corp.

$0.03-8.60%$6.1M

股票表现

1D-1.95%

1W+0.67%

1M-12.89%

3M-31.62%

YTD-60.16%

1Y-76.47%

5Y+15000.00%

关于 Bioxytran, Inc.

CEODavid Platt

IPO DateJan 5, 2010

Employees3

CountryUS

Websitebioxytraninc.com

Bioxytran, Inc. is a pharmaceutical firm operating in the clinical development phase, dedicated to creating, producing, and marketing medicinal treatments for oxygen deficiency (hypoxia) in people. It…

Biotechnology HealthcareOTCUS

关于股票概览与关键数据

Bioxytran, Inc.（BIXT）是 Biotechnology 行业的 Healthcare 类公司，于 Jan 5, 2010 在 OTC 上市。截至最近交易日，BIXT 股价为 $0.03，市值约为 $3.4M。过去12个月累计回报 -76.47%，年初至今回报 -60.16%。

2025 财年 Bioxytran, Inc. 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Bioxytran, Inc.（BIXT）股价为 $0.03，在 OTC 上市，52周区间为 $0.03 – $0.14。

BIXT 最新股价BIXT quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议